Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Lack of Physician Rationale for Declined GDR of Psychotropic Medications

Wewoka, Oklahoma Survey Completed on 03-05-2026

Penalty

Fine: $130,240
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a physician documented a clinical rationale when declining gradual dose reduction (GDR) requests for psychotropic medications, as required by facility policy and CMS guidance. The facility’s undated "Gradual Dose Reduction (GDR) Policy-Oklahoma Nursing Facility" stated that residents prescribed psychotropic medications should receive appropriate GDRs and non-pharmacologic interventions, and that the physician would document a rationale if a reduction was contraindicated. A consultant pharmacist completed a monthly medication regimen review on 12/31/25 for a resident admitted on 10/16/23 with diagnoses including paranoid schizophrenia, chronic pain, restless leg syndrome, paraplegia, major depressive disorder, obsessive compulsive disorder, hypertension, catheter status, and anxiety. The resident’s quarterly MDS dated 12/16/25 showed a BIMS score of 15, indicating intact cognition, and listed multiple medications, including Depakote for behavior management, Trazodone for sleep, Trintellix and Desvenlafaxine for depression, Meloxicam for arthritis, Olanzapine and Quetiapine for schizophrenia, Fesoterodine for neurogenic bladder, and several PRN medications. During the 12/31/25 medication regimen review, the consultant pharmacist requested consideration of a dose reduction in Quetiapine 300 mg at bedtime and Trintellix 20 mg daily, asking if a reduction in Quetiapine to 250 mg at bedtime was appropriate. On the review form, the physician checked "no, a reduction is contraindicated due to:" for both Quetiapine and Trintellix but did not document any rationale in the space provided. The Assistant Director of Nursing later verified that the GDR request for these medications was signed by the physician, that the physician had declined the dose reduction requests, and that no rationale was documented. The ADON also confirmed that the GDR request was noted by a nurse and there was no documentation that nursing staff sought or obtained a rationale from the physician for declining the GDR requests. The ADON identified that 47 residents in the facility were receiving psychotropic medications.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙